Search

This article examines the impact of the COVID-19 pandemic on endoscopic pituitary surgery at a pituitary center of excellence. The study compared patients who underwent surgery before the pandemic (January 2015 to March 2020) with those who had surgery during the pandemic (March 2020 to September 2022). The results showed that patients who presented during the pandemic tended to be more frail and have more comorbidities. They were also more likely to have larger adenomas and require additional surgical approaches. Despite these changes, the length of stay and readmission rate remained stable, indicating the safety of the procedure during the pandemic. [Extracted from the article]

This article discusses the outcomes of the endoscopic endonasal approach (EEA) for nonfunctional pituitary adenomas (NFPAs) in elderly patients. The study involved a retrospective review of NFPAs in patients aged 65 and older who underwent EEA between 2007 and 2022 at a single medical center. The results showed that EEA was a safe and effective option for NFPA resection in elderly patients, with high rates of visual recovery postoperatively and acceptable rates of gross total resection (GTR). The study also identified risk factors for progression and subtotal resection, but found no associations between postoperative complications and age or frailty scores. [Extracted from the article]